Bank of America’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,022
Closed -$10K 8479
2022
Q2
$10K Sell
1,022
-26,687
-96% -$263K ﹤0.01% 7412
2022
Q1
$272K Hold
27,709
﹤0.01% 6271
2021
Q4
$270K Buy
+27,709
New +$272K ﹤0.01% 6320

Other funds holding FLAC

Bank of America's FLAC Position: Q3 2022 in Review

Bank of America sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q3 2022, closing a stake of 1,022 shares — an estimated $10K sold.

Bank of America first reported a position in FLAC in Q4 2021 and held it in 3 quarters. The position peaked at $272K in Q1 2022. 52 funds tracked by Wall St. Rank hold FLAC as of Q3 2022.

  • Bank of America reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Bank of America sold 1,022 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q3 2022, an estimated $10K.
  • Bank of America first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q4 2021 and held it in 3 quarters.
  • Bank of America's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $272K in Q1 2022.
  • 52 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q3 2022.

Based on Bank of America's 13F filing for Q3 2022, filed 14 Nov 2022.